JP2007531731A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531731A5
JP2007531731A5 JP2007506319A JP2007506319A JP2007531731A5 JP 2007531731 A5 JP2007531731 A5 JP 2007531731A5 JP 2007506319 A JP2007506319 A JP 2007506319A JP 2007506319 A JP2007506319 A JP 2007506319A JP 2007531731 A5 JP2007531731 A5 JP 2007531731A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
formula
independently
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007531731A (ja
JP4991037B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011124 external-priority patent/WO2005094897A2/en
Publication of JP2007531731A publication Critical patent/JP2007531731A/ja
Publication of JP2007531731A5 publication Critical patent/JP2007531731A5/ja
Application granted granted Critical
Publication of JP4991037B2 publication Critical patent/JP4991037B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506319A 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体 Expired - Fee Related JP4991037B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55940504P 2004-04-01 2004-04-01
US60/559,405 2004-04-01
US58699204P 2004-07-08 2004-07-08
US60/586,992 2004-07-08
PCT/US2005/011124 WO2005094897A2 (en) 2004-04-01 2005-03-31 Pegylated ion channel modulating compounds

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2008088707A Division JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088708A Division JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Publications (3)

Publication Number Publication Date
JP2007531731A JP2007531731A (ja) 2007-11-08
JP2007531731A5 true JP2007531731A5 (enExample) 2008-05-15
JP4991037B2 JP4991037B2 (ja) 2012-08-01

Family

ID=34972985

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Ｐｅｇ化イオンチャネル調節化合物

Country Status (6)

Country Link
US (2) US7786119B2 (enExample)
EP (1) EP1729814A2 (enExample)
JP (4) JP4954864B2 (enExample)
CA (1) CA2561733A1 (enExample)
MX (1) MXPA06011420A (enExample)
WO (1) WO2005094897A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
WO2005097087A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
US7977373B2 (en) 2004-04-01 2011-07-12 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US7754897B2 (en) * 2005-06-15 2010-07-13 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
MXPA06011420A (es) * 2004-04-01 2007-04-20 Cardiome Pharma Corp Compuestos pegilados de modulacion de canal de iones.
US8692002B2 (en) 2004-11-18 2014-04-08 Cardiome Pharma Corp. Synthetic process for aminocyclohexyl ether compounds
JP2007131597A (ja) * 2005-11-11 2007-05-31 Toray Fine Chemicals Co Ltd ベンジルオキシピロリジン誘導体の製造方法
JP5004067B2 (ja) * 2005-10-31 2012-08-22 東レ・ファインケミカル株式会社 ベンジルオキシ含窒素環状化合物の製造法
CA2627502C (en) * 2005-10-31 2014-04-01 Toray Fine Chemicals Co., Ltd. Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
JP5004073B2 (ja) * 2006-06-13 2012-08-22 東レ・ファインケミカル株式会社 光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体及びその製造法
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
WO2009032286A2 (en) * 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Oligomer-calcium channel blocker conjugates
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
BRPI0919920A2 (pt) * 2008-10-22 2016-02-16 Acucela Inc compostos para tratamento de doenças e desordens oftálmicas
CA2754395A1 (en) * 2009-04-03 2010-10-07 The University Of Toledo A peg-albumin composition having at least one protected thiol region as a platform for medications
US8993614B2 (en) 2012-03-15 2015-03-31 F. Hoffmann-La Roche Ag Substituted pyrrolidine-2-carboxamides
US9974759B2 (en) 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684728A (en) * 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
EP0317780B1 (en) 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
US6517824B1 (en) * 1990-05-14 2003-02-11 University Of Medicine & Denistry Of New Jersey Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US20030186869A1 (en) * 1990-05-14 2003-10-02 George Poiani Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5244889A (en) 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5298492A (en) 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US6191105B1 (en) * 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
KR0156780B1 (ko) 1993-06-11 1998-11-16 나이토 하루오 아미노산 유도체
WO1995008544A1 (en) * 1993-09-24 1995-03-30 The University Of British Columbia Aminocyclohexylesters and uses thereof
WO1995026325A2 (en) * 1994-03-25 1995-10-05 Isotechnika Inc. Enhancement of the efficacy of drugs by deuteration
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
EP0932399B1 (en) 1996-03-12 2006-01-04 PG-TXL Company, L.P. Water soluble paclitaxel prodrugs
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
WO1998019682A1 (en) 1996-11-01 1998-05-14 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and uses therefor
EP0884325A1 (en) 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
US6342507B1 (en) * 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
DK0991660T3 (da) * 1997-10-08 2006-02-13 Isotechnika Inc Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler
PT1087934E (pt) * 1998-04-01 2004-07-30 Cardiome Pharma Corp Compostos de eter de aminociclo-hexilo e as suas utilizacoes
WO1999064045A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Novel therapeutic agents for membrane transporters
JP2002527459A (ja) * 1998-10-20 2002-08-27 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 粘膜表面を水和する方法
WO2000047547A2 (en) 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
BR0010151A (pt) 1999-04-29 2002-06-11 Merck Patent Gmbh Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais
CA2311483A1 (en) 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
WO2002028412A1 (en) 2000-10-05 2002-04-11 Zealand Pharmaceuticals A/S Novel use of peptide
JP2004509949A (ja) * 2000-09-26 2004-04-02 ザ　ユニバーシティ　オブ　アリゾナ　ファウンデーション 化合物および癌またはウイルス性感染症治療におけるその使用方法
JP2002105067A (ja) 2000-09-28 2002-04-10 Teijin Ltd ２−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
US7057053B2 (en) * 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) * 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
BR0211318B1 (pt) * 2001-07-02 2010-12-14 mÉtodo de interligaÇço de uma coluna de ascensço com uma tubulaÇço de fluxo e conjunto para conexço de uma coluna de ascensço.
US6623729B2 (en) * 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
JP2005501052A (ja) * 2001-07-31 2005-01-13 イムノメディクス， インコーポレイテッド ポリマー送達系
JP2003113084A (ja) 2001-10-02 2003-04-18 Mitsubishi Pharma Corp 肺高血圧症の治療及び／または予防薬
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
TW200407310A (en) 2002-06-07 2004-05-16 Glaxo Group Ltd Compounds
BR0312176A (pt) * 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmaceutica, uso de um composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso, processo para a preparação de um composto, novo intermediario e processo para a preparação de um novo intermediario
MXPA04012802A (es) * 2002-06-28 2005-04-19 Idenix Cayman Ltd Ester 2'-c-metil-3'-o-l-valina de ribofuranosil-citidina para el tratamiento de infecciones por flaviviridae.
WO2004014973A2 (en) 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
WO2004082585A2 (en) 2003-03-20 2004-09-30 Sirus Pharmaceuticals Ltd Water-soluble conjugates of phenytoin
WO2004098525A2 (en) 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
CA2524323C (en) * 2003-05-02 2012-05-15 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
KR100495009B1 (ko) * 2003-07-02 2005-06-14 삼성전자주식회사 화상형성 장치의 전사벨트 텐션 자동 인가 장치
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
WO2005079861A2 (en) * 2004-02-13 2005-09-01 Safeway Investments Ltd. Polymeric water soluble prodrugs
US7754897B2 (en) * 2005-06-15 2010-07-13 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
US7977373B2 (en) * 2004-04-01 2011-07-12 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US7705036B2 (en) * 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
MXPA06011420A (es) * 2004-04-01 2007-04-20 Cardiome Pharma Corp Compuestos pegilados de modulacion de canal de iones.
WO2005097203A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Serum protein conjugates of ion channel modulating compounds and uses thereof
US7845611B1 (en) * 2007-11-16 2010-12-07 Sholander Alfred M Door operated page turner device, system and method for books

Similar Documents

Publication Publication Date Title
JP2007531731A5 (enExample)
ES2620446T3 (es) Nuevo compuesto heterocíclico bicíclico
JP5387997B2 (ja) 血管の収縮または拡張による疾患治療剤
JP6760249B2 (ja) 三環性スピロ化合物
JP7759877B2 (ja) 治療用化合物
KR940007021A (ko) 흥분성 아미노산 수용체 길항물질
US10555951B2 (en) Targeted treatment of leiomyosarcoma
JP2007531766A5 (enExample)
JP2005531516A5 (enExample)
BR112019012688A2 (pt) método para produção de derivado de 7h-pirrol[2,3-d]pirimidina e intermediário sintético do mesmo
JP2005504011A5 (enExample)
JP2006504621A5 (enExample)
CN108366979B (zh) 与泛素化－蛋白酶体系统有关的化合物及医药组合物
CN103080107A (zh) 作为蛋白激酶抑制剂的杂芳基化合物和组合物
EA031424B1 (ru) Производные 6-алкинилпиридина в качестве миметиков белка smac
WO2014047393A1 (en) N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
CN112638376B (zh) 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法
WO2006043655A1 (ja) 吸入用医薬組成物
JP6922712B2 (ja) 医薬用途
ES2609459T3 (es) Compuestos heterocíclicos condensados y su uso
KR20230117574A (ko) 암 치료를 위한 metap2 억제제 및 cdk4/6 억제제의 조합
MX2024010403A (es) Derivado de imidazopiridazina, y método de preparación del mismo, composición farmacéutica del mismo y uso del mismo
CA3157778A1 (en) Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
JP2007527411A5 (enExample)
TW201805267A (zh) 與泛素化-蛋白酶體系統有關之化合物及醫藥組合物